1. Home
  2. SLP vs DSM Comparison

SLP vs DSM Comparison

Compare SLP & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLP
  • DSM
  • Stock Information
  • Founded
  • SLP 1996
  • DSM 1989
  • Country
  • SLP United States
  • DSM United States
  • Employees
  • SLP N/A
  • DSM N/A
  • Industry
  • SLP EDP Services
  • DSM Investment Managers
  • Sector
  • SLP Technology
  • DSM Finance
  • Exchange
  • SLP Nasdaq
  • DSM Nasdaq
  • Market Cap
  • SLP 261.0M
  • DSM 280.8M
  • IPO Year
  • SLP 1997
  • DSM N/A
  • Fundamental
  • Price
  • SLP $13.64
  • DSM $5.47
  • Analyst Decision
  • SLP Buy
  • DSM
  • Analyst Count
  • SLP 7
  • DSM 0
  • Target Price
  • SLP $29.50
  • DSM N/A
  • AVG Volume (30 Days)
  • SLP 1.0M
  • DSM 161.7K
  • Earning Date
  • SLP 07-14-2025
  • DSM 01-01-0001
  • Dividend Yield
  • SLP N/A
  • DSM 3.97%
  • EPS Growth
  • SLP N/A
  • DSM N/A
  • EPS
  • SLP N/A
  • DSM N/A
  • Revenue
  • SLP $80,383,000.00
  • DSM N/A
  • Revenue This Year
  • SLP $19.69
  • DSM N/A
  • Revenue Next Year
  • SLP $6.95
  • DSM N/A
  • P/E Ratio
  • SLP N/A
  • DSM N/A
  • Revenue Growth
  • SLP 20.01
  • DSM N/A
  • 52 Week Low
  • SLP $12.39
  • DSM $4.69
  • 52 Week High
  • SLP $42.11
  • DSM $6.05
  • Technical
  • Relative Strength Index (RSI)
  • SLP 31.12
  • DSM 36.42
  • Support Level
  • SLP $12.97
  • DSM $5.45
  • Resistance Level
  • SLP $13.55
  • DSM $5.67
  • Average True Range (ATR)
  • SLP 0.77
  • DSM 0.05
  • MACD
  • SLP 0.24
  • DSM -0.01
  • Stochastic Oscillator
  • SLP 21.93
  • DSM 9.09

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About DSM BNY Mellon Strategic Municipal Bond Fund Inc.

BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.

Share on Social Networks: